Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Irinotecan
Metastatic Malignant Neoplasm
Incyte Corporation
P3
BB
(68)
Irinotecan
Primary Peritoneal Carcinoma
Tianjin Medical University Cancer Institute and Hospital
P3
BB
(68)
Irinotecan
Breast Carcinoma
OHSU Knight Cancer Institute
P3
BB
(68)
Lazertinib
Non-Small Cell Lung Carcinoma
Janssen Research & Development, LLC
P3
BB
(68)
L-Cysteinamide, D-Phenylalanyl-L-Cysteinyl-L-Phenylalanyl-D-Tryptophyl-L-Lysyl-L-Threonyl-N-(2-Hydroxy-1-(Hydroxymethyl)Propyl)-, Cyclic (2->7)-Disulfide, (R-(R*,R*))-
Hepatocellular Carcinoma
Clinica Universidad de Navarra, Universidad de Navarra
P3
BB
(68)
Lenalidomide
Diffuse Large B-Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
P3
BB
(68)
Lenalidomide
B-Cell Chronic Lymphocytic Leukemia
Vitebsk Regional Clinical Cancer Centre
P3
BB
(68)
Leuporelin
Prostate Adenocarcinoma
Mayo Clinic
P3
BB
(68)
Memantine
Cognitive Disorder
UNC Lineberger Comprehensive Cancer Center
P3
BB
(68)
Methotrexate
Acute Undifferentiated Leukemia
Therapeutic Advances in Childhood Leukemia Consortium
P3
BB
(68)
Methotrexate
B-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BB
(68)
Methotrexate
Graft Versus Host Disease
University of Michigan Rogel Cancer Center
P3
BB
(68)
Methotrexate
Non-Hodgkin Lymphoma
Sun Yat-sen University
P3
BB
(68)
Methotrexate
Plasma Cell Myeloma
Poseida Therapeutics, Inc.
P3
BB
(68)
Nilutamide
Prostate Cancer
VA Office of Research and Development
P3
BB
(68)
Nivestim
Myeloproliferative Neoplasm
City of Hope Medical Center
P3
BB
(68)
Nivestim
HIV Infectious Disease
Fred Hutchinson Cancer Center
P3
BB
(68)
Nivestim
Metastatic Malignant Neoplasm
Mayo Clinic
P3
BB
(68)
Obinutuzumab
B-Cell Chronic Lymphocytic Leukemia
Paolo Caimi, MD
P3
BB
(68)
Oxaliplatin
Gallbladder Cancer
Tianjin Medical University Cancer Institute and Hospital
P3
BB
(68)
Oxaliplatin
Gastroesophageal Adenocarcinoma
Memorial Sloan Kettering Cancer Center
P3
BB
(68)
Oxaliplatin
Gastroesophageal Junction Adenocarcinoma
Alliance for Clinical Trials in Oncology
P3
BB
(68)
Oxaliplatin
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer Center
P3
BB
(68)
Oxaliplatin
Rectum Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University
P3
BB
(68)
Oxaliplatin
Rectal Neoplasm
Chongqing University Cancer Hospital
P3
BB
(68)
Showing 1501 to 1525 of 42,301 assets
Previous
Page 61 of 1693
Next